🇺🇸 FDA
Patent

US 8791149

Methods of treating traumatic brain injury using pro-neurogenic compounds

granted A61KA61K31/403A61K31/4035

Quick answer

US patent 8791149 (Methods of treating traumatic brain injury using pro-neurogenic compounds) held by The Board of Regents of the University of Texas System expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/403, A61K31/4035, A61K31/404, A61K31/4045